We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$10.2B
AUM Growth
+$16.3M
(+0.16%)
Cap. Flow
-$433M
Cap. Flow
% of AUM
-4.26%
Top 10 Holdings %
Top 10 Hldgs %
18.51%
Holding
2,653
New
50
Increased
1,175
Reduced
580
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$26.6M |
| 2 |
Canadian National Railway
CNI
|
+$21.1M |
| 3 |
KBR
KBR
|
+$20M |
| 4 |
Kimco Realty
KIM
|
+$16.5M |
| 5 |
Voya Financial
VOYA
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$24.9M |
| 2 |
Allstate
ALL
|
+$19.3M |
| 3 |
Chevron
CVX
|
+$18.7M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$16.6M |
| 5 |
Pfizer
PFE
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.6% |
| 2 | Technology | 14.64% |
| 3 | Healthcare | 12.06% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CACQ
1601
DELISTED
Caesars Acquisition Company
CACQ
| $62K | ﹤0.01% |
3,268
| – | – |
|
|
BEAT
1602
DELISTED
BioTelemetry, Inc.
BEAT
| $62K | ﹤0.01% |
1,847
+301
| +19% | +$8.98K |
|
|
AMED
1603
DELISTED
Amedisys
AMED
| $61K | ﹤0.01% |
975
+187
| +24% | +$10.9K |
|
|
FFIC
1604
DELISTED
Flushing Financial
FFIC
| $61K | ﹤0.01% |
2,160
+454
| +27% | +$12.7K |
|
1605
Quaker Houghton
KWR
$2.98B
| $61K | ﹤0.01% |
422
+68
| +19% | +$9.62K |
|
1606
La-Z-Boy
LZB
$1.67B
| $61K | ﹤0.01% |
1,878
+579
| +45% | +$16.3K |
|
1607
MillerKnoll
MLKN
$1.65B
| $61K | ﹤0.01% |
2,019
+348
| +21% | +$11.1K |
|
1608
OR Royalties Inc
OR
$6.08B
| $61K | ﹤0.01% |
5,010
| – | – |
|
|
CBM
1609
DELISTED
Cambrex Corporation
CBM
| $61K | ﹤0.01% |
1,015
+170
| +20% | +$9.55K |
|
|
BPMC
1610
DELISTED
Blueprint Medicines
BPMC
| $60K | ﹤0.01% |
1,186
+188
| +19% | +$7.98K |
|
1611
City Holding Co
CHCO
$2.05B
| $60K | ﹤0.01% |
917
| – | – |
|
1612
Chord Energy
CHRD
$7.4B
| $60K | ﹤0.01% |
7,445
-6,732
| -47% | -$73.7K |
|
1613
Coca-Cola Consolidated
COKE
$12.3B
| $60K | ﹤0.01% |
2,640
| – | – |
|
1614
Casella Waste Systems
CWST
$5.69B
| $60K | ﹤0.01% |
+3,678
| New | +$54.4K |
|
1615
Genworth Financial
GNW
$3.7B
| $60K | ﹤0.01% |
15,844
-96,850
| -86% | -$367K |
|
1616
Piper Sandler
PIPR
$5.11B
| $60K | ﹤0.01% |
3,988
| – | – |
|
1617
Varonis Systems
VRNS
$5.02B
| $60K | ﹤0.01% |
4,827
-22,200
| -82% | -$254K |
|
|
HTLF
1618
DELISTED
Heartland Financial USA, Inc.
HTLF
| $60K | ﹤0.01% |
1,268
+267
| +27% | +$12.7K |
|
|
NRE
1619
DELISTED
NorthStar Realty Europe Corp.
NRE
| $60K | ﹤0.01% |
4,722
+1,070
| +29% | +$12.9K |
|
|
TIER
1620
DELISTED
TIER REIT, Inc.
TIER
| $60K | ﹤0.01% |
3,229
| – | – |
|
|
AVNS
1621
DELISTED
Avanos Medical
AVNS
| $59K | ﹤0.01% |
1,496
+254
| +20% | +$9.6K |
|
1622
Center Bancorp
CNOB
$1.67B
| $59K | ﹤0.01% |
2,632
+751
| +40% | +$17.1K |
|
1623
Helios Technologies
HLIO
$2.71B
| $59K | ﹤0.01% |
1,386
+372
| +37% | +$15K |
|
1624
SM Energy
SM
$7.17B
| $59K | ﹤0.01% |
3,542
+475
| +15% | +$9.43K |
|
1625
Applied Optoelectronics
AAOI
$10.6B
| $58K | ﹤0.01% |
+936
| New | +$54.7K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2017 Portfolio in Review
As of Q2 2017, Zurich Cantonal Bank held 2,653 positions worth $10.2B, up 0.16% from $10.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Zurich Cantonal Bank withdrew a net $433M in Q2 2017, closing 131 positions and reducing 580 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $16.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Zurich Cantonal Bank opened a new position in DXC Technology worth $14M.
- Zurich Cantonal Bank's largest Q2 2017 buy was DXC Technology: 211,545 shares worth $14M.
- Zurich Cantonal Bank added most to Jazz Pharmaceuticals in Q2 2017, an estimated $26.6M increase.
- Zurich Cantonal Bank's biggest Q2 2017 reduction was Check Point Software Technologies, cutting an estimated $24.9M.
- Zurich Cantonal Bank fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $16.6M.
- Zurich Cantonal Bank's ten largest holdings make up 19% of its $10.2B portfolio in Q2 2017.
- Zurich Cantonal Bank opened 50 new positions and closed 131 in Q2 2017.
- Zurich Cantonal Bank's portfolio value rose 0.16% quarter-over-quarter to $10.2B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2017, filed 8 Aug 2017.